Literature DB >> 18025150

Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

Yuichi Aiba1, Megumi Kameyama, Tetsuo Yamazaki, Thomas F Tedder, Tomohiro Kurosaki.   

Abstract

Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cells. The YXXM motifs in BCAP and CD19 are crucial for regulating B-cell development in that mutation of these motifs abrogated their ability to induce BCR-mediated Akt activation as well as to promote B-cell development. Furthermore, the developmental defect in CD19(-/-)BCAP(-/-) B cells was partly relieved by introducing a constitutively active form of PI3K or PDK1. Together, our data suggest that BCAP and CD19 have complementary roles in BCR-mediated PI3K activation, thereby, at least in part, contributing to B-cell development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025150     DOI: 10.1182/blood-2007-08-109769

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Authors:  Minjian Ni; Alexander W MacFarlane; Michelle Toft; Clifford A Lowell; Kerry S Campbell; Jessica A Hamerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

Review 3.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

4.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

Review 5.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

Review 6.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

7.  Ncking BCR-mediated PI3K activation.

Authors:  Jennifer L Cannons; Fang Zhao; Pamela L Schwartzberg
Journal:  EMBO Rep       Date:  2013-08-23       Impact factor: 8.807

8.  Nck, a missing adaptor between the B-cell receptor complex and the BCAP/PI3K/Akt pathway.

Authors:  Chuen-Miin Leu
Journal:  Cell Mol Immunol       Date:  2013-11-25       Impact factor: 11.530

Review 9.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

10.  Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation.

Authors:  Teruhito Yasui; Kaori Sakakibara-Yada; Taki Nishimura; Kentaro Morita; Satoru Tada; George Mosialos; Elliott Kieff; Hitoshi Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.